Uncategorized – Page 10 – Wealth Creation Investing

Originally appeared on E! Online Jelly Roll is sharing intimate details of his weight loss journey. After the Grammy nominee lost over 100 pounds

Lose weight 'effortlessly' with tasty fruit drink branded 'natural Ozempic'

November 21, 2024November 21, 2024

Posted By: admin

Ozempic is increasingly becoming the go-to drug for those keen on weight loss. Originally prescribed to tackle type 2 diabetes, Ozempic now being hailed

Seven investing ideas from the big banks’ 2025 previews

November 21, 2024November 21, 2024

Posted By: admin

It’s about this time when we start to get the reminders that the end of the year is rushing up to meet us. Party

13 Must-Read Investing Books

November 21, 2024November 21, 2024

Posted By: admin

getty When starting or advancing in your investing journey, there is no shortage of perspectives on how you should invest or in what you

Why is it so difficult to lose weight? ‘Fat cells’ may be the reason

November 21, 2024November 21, 2024

Posted By: admin

Losing weight is a challenging process, but keeping it off can be even more difficult. Researchers have been investigating why this happens, and they

What Are Compounded GLP-1 Medications for Weight Loss?

November 21, 2024November 21, 2024

Posted By: admin

Vanessa Gibbs November 21, 2024 at 5:58 AM Carolina Rudah/Istockphoto GLP-1s (glucagon-like peptide-1 receptor agonists) are medications used to treat type 2 diabetes and

Robo-advisor: How to start investing right away

November 21, 2024November 22, 2024

Posted By: admin

If you want help managing your investments but don’t want to pay a financial advisor, a robo-advisor may be a good alternative. A robo-advisor

8 Best Carbs To Eat at Breakfast for Weight Loss

November 21, 2024November 21, 2024

Posted By: admin

When it comes to breakfast , it’s essential to make choices that will give you steady energy, keep you full, and avoid blood sugar

High demand for weight loss drugs like Ozempic and Wegovy is impacting employer health care costs—but it can be critical for retaining talent

November 21, 2024November 21, 2024

Posted By: admin

Brit Morse November 21, 2024 at 4:00 AM Woman’s hand with semaglutide injection for weight loss. (Iuliia Burmistrova—Getty Images) The weight loss drug revolution

Passive Investing Could Crash the Market, Swiss Re Institute Analysts Warn

November 21, 2024November 22, 2024

Posted By: admin

<!–> The big picture: The institute analysts are predicting that world inflation-adjusted gross domestic product, or overall income, will increase 2.8% in 2025 and

wealthcreationinvesting.com is not an investment advisor and is not registered with the U.S. Securities and Exchange Commission or the Financial Industry Regulatory Authority. Further, owners, employees, agents or representatives of wealthcreationinvesting.com are not acting as investment advisors and might not be registered with the U.S. Securities and Exchange Commission or the Financial Industry Regulatory.

The sender of this email makes no representations or warranties concerning the products, practices or procedures of any company or entity mentioned or recommended in this email, and makes no representations or warranties concerning said company or entity’s compliance with applicable laws and regulations, including, but not limited to, regulations promulgated by the SEC or the CFTC. The sender of this email may receive a portion of the proceeds from the sale of any products or services offered by a company or entity mentioned or recommended in this email. The recipient of this email assumes responsibility for conducting its own due diligence on the aforementioned company or entity and assumes full responsibility, and releases the sender from liability, for any purchase or order made from any company or entity mentioned or recommended in this email.

The content on any of wealthcreationinvesting.com websites, products or communication is for educational purposes only. Nothing in its products, services, or communications shall be construed as a solicitation and/or recommendation to buy or sell a security. Trading stocks, options and other securities involves risk. The risk of loss in trading securities can be substantial. The risk involved with trading stocks, options and other securities is not suitable for all investors. Prior to buying or selling an option, an investor must evaluate his/her own personal financial situation and consider all relevant risk factors. See: Characteristics and Risks of Standardized Options.

The information presented in this site is not intended to be used as the sole basis of any investment decisions, nor should it be construed as advice designed to meet the investment needs of any particular investor. Nothing in our research constitutes legal, accounting or tax advice or individually tailored investment advice. Our research is prepared for general circulation and has been prepared without regard to the individual financial circumstances and objectives of persons who receive or obtain access to it. Our research is based on sources that we believe to be reliable. However, we do not make any representation or warranty, expressed or implied, as to the accuracy of our research, the completeness, or correctness or make any guarantee or other promise as to any results that may be obtained from using our research. To the maximum extent permitted by law, neither we, any of our affiliates, nor any other person, shall have any liability whatsoever to any person for any loss or expense, whether direct, indirect, consequential, incidental or otherwise, arising from or relating in any way to any use of or reliance on our research or the information contained therein. Some discussions contain forward looking statements which are based on current expectations and differences can be expected. All of our research, including the estimates, opinions and information contained therein, reflects our judgment as of the publication or other dissemination date of the research and is subject to change without notice. Further, we expressly disclaim any responsibility to update such research. Investing involves substantial risk. Past performance is not a guarantee of future results, and a loss of original capital may occur. No one receiving or accessing our research should make any investment decision without first consulting his or her own personal financial advisor and conducting his or her own research and due diligence, including carefully reviewing any applicable prospectuses, press releases, reports and other public filings of the issuer of any securities being considered. None of the information presented should be construed as an offer to sell or buy any particular security. As always, use your best judgment when investing.

Disclaimer: Past performance is no guarantee of future performance. This product is for educational purposes only. Practical application of the products herein are at your own risk and wealthcreationinvesting.com, its partners, representatives and employees assume no responsibility or liability for any use or mis-use of the product. Please contact your financial advisor for specific financial advice tailored to your personal circumstances. Any trades shown are hypothetical example and do not represent actual trades. Actual results may differ. Nothing here in constitutes a recommendation respecting the particular security illustrated.